This study is looking at how often women with overactive bladder (OAB) should receive botulinum toxin (Botox) injections. OAB causes symptoms like a sudden urge to urinate and frequent urination. The study wants to see if letting patients decide when they need their next injection, based on their symptoms, works better than the standard 6-month schedule. You would receive a standard botulinum toxin injection into your bladder. Then, you'd either follow up at a set 6-month interval or when your symptoms return. The main goal is to see if patient-directed follow-up changes the time between injections and improves symptom control and satisfaction. This study is for women aged 18 and older who have been diagnosed with OAB and are considering botulinum toxin injections. The study aims to enroll 100 participants, but its current recruitment status is unclear.

Study design

This interventional study plans to enroll 100 women. Participants will be randomly assigned to either a standard 6-month follow-up or a patient-directed follow-up schedule.

What's involved

You would undergo a standard botulinum toxin injection into your bladder. You would then follow up for repeat injections either at a 6-month interval or at your own self-determined time based on your symptoms.

Compensation

Not stated in the trial record.

Follow-up

The primary endpoint, injection interval, will be measured for up to 365 days from the initial injection.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.